BMC Immunology (Jun 2012)

A novel splice variant of folate receptor 4 predominantly expressed in regulatory T cells

  • Tian Yi,
  • Wu Guoqiang,
  • Xing Jun-Chao,
  • Tang Jun,
  • Zhang Yi,
  • Huang Ze-Min,
  • Jia Zheng-Cai,
  • Zhao Ren,
  • Tian Zhi-Qiang,
  • Wang Shu-Feng,
  • Chen Xiao-Ling,
  • Wang Li,
  • Wu Yu-Zhang,
  • Ni Bing

DOI
https://doi.org/10.1186/1471-2172-13-30
Journal volume & issue
Vol. 13, no. 1
p. 30

Abstract

Read online

Abstract Background Regulatory T cells (Tregs) are required for proper maintenance of immunological self-tolerance and immune homeostasis. Folate receptor 4 (FR4) is expressed at high levels in transforming growth factor-beta (TGF-β)-induced Tregs and natural Tregs. Moreover, antibody-mediated targeting of FR4 is sufficient to mediate Treg depletion. Results In this study, we describe a novel FR4 transcript variant, FR4D3, in which exon 3 is deleted. The mRNA of FR4D3 encodes a FR4 variant truncated by 189 bp. FR4D3 was found to be predominantly expressed in CD4+CD25+ Treg cells. Overexpression of FR4D3 in CD4+CD25+ Treg cells in vitro stimulated proliferation, which may modulate the ability of these cells to bind and incorporate folic acid. Conclusions Our results suggested that high levels of FR4D3 may be critical to support the substantial proliferative capacity of Treg cells.

Keywords